SCHEMBL30411920

SCHEMBL30411920

O=C(Nc1sccc1C(=O)O)OC(Cl)(Cl)Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.58
PTPRB P23467 1/20 0.58
PTPN6 P29350 1/20 0.58
ABCC1 P33527 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
ACLY P53396 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
PTK2 Q05397 1/20 0.41
MAPK8 P45983 2/20 0.41
MAPK10 P53779 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1703501 0.84 PTPN2 (0.58) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL10470287 0.77 ABCC1 (0.58) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL13764835 0.77 PTPN2 (0.72) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL10741969 0.75 PTPN2 (0.64) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL1704195 0.74 PTK2 (0.71) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL5836577 0.74 PTPN2 (1.00) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL5550829 0.74 PTPN2 (0.68) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL4141410 0.73 PTPN2 (0.62) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL19237020 0.71 PTPN2 (0.64) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2
SCHEMBL14231616 0.71 PTPN2 (0.58) PTPN2PTPRBPTPN6ABCC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143197-A1 THIENO PYRIMIDINES AS FERROPORTIN INHIBITORS Global Blood Therapeutics, Inc. (US) 2023-03-08 EP disclosed